Previous studies demonstrated that h-PGDS agonists and the production of h-PGDS-derived PGD2 in nonhematopoietic cells (alveolar endothelial and epithelial cells) could be beneficial for alleviating acute lung injury [13]. This evidence concerns the gene PTGDS and injury.